市場調查報告書 - 247572

睡眠呼吸中止症的診斷・治療裝置市場：全球的終端使用者分析、競爭環境、將來預測

Sleep Apnea Diagnostic & Therapeutic Devices Market: Global End-user Analysis, Competitive Landscape & Forecast to 2017
出版商 Markets and Markets
出版日期 2012年07月25日 內容資訊 英文 318 Pages
價格
睡眠呼吸中止症的診斷・治療裝置市場：全球的終端使用者分析、競爭環境、將來預測 Sleep Apnea Diagnostic & Therapeutic Devices Market: Global End-user Analysis, Competitive Landscape & Forecast to 2017
出版日期: 2012年07月25日 內容資訊: 英文 318 Pages
簡介

睡眠障礙蔓延全球，其重大原因被認為是阻塞性睡眠呼吸中止症（OSA），85%的睡眠時無呼吸症狀來自該障礙，罹患該病者數達1億，其中的80%處於未診斷的狀態。

本報告，將睡眠呼吸中止症相關裝置的全球市場分為診斷裝置與治療裝置，並細分個別的產品種類，徹底分析過去3年的銷售價值及數量，同時進行將來預測，並彙整全球各地區（北美、歐洲、亞洲、其他）及各裝置使用者層的分析資料，由下列摘要形式闡述。

第1章 簡介

  • 重要判明事項
  • 報告內容
  • 調查對象市場
  • 利害關係人
  • 調查方法
    • 市場規模
    • 市佔率
    • 二次情報來源所獲得的重點
    • 一次情報來源所獲得的重點
    • 前提條件

第2章 報告摘要

第3章 市場概要

  • 簡介
    • 睡眠的階段
    • 睡眠障礙
    • 睡眠呼吸中止症
    • 睡眠呼吸中止症說明分析
    • 睡眠呼吸中止症分類
    • 原因
    • 徵兆及症狀
    • 風險因子
    • 診斷方法
    • 治療選項
    • 併發症
  • 市場動態
    • 波特的五力分析
    • 促進因素
    • 限制因素
    • 主要參與企業別市佔率

第4章 全球的睡眠呼吸中止症相關裝置市場 - 部門別

  • 簡介

第5章 全球的睡眠呼吸中止症診斷裝置市場 - 產品別

  • 簡介
  • 睡眠多項生理檢查（PSG）裝置
  • 呼吸多項生理檢查
  • 2通道篩檢裝置（鼻漏感測器：SPO2）
  • 單通道篩檢裝置（脈搏血氧濃度計）
  • 腕動計系統

第6章 全球的睡眠呼吸中止症治療裝置市場 - 產品別

  • 簡介
  • 正壓呼吸器（PAP）裝置
  • 臉部介面
  • 伺服輔助換氣（ASV）
  • 呼吸道清潔系統
  • 氧氣供給裝置
  • 附加物件
  • 口腔裝置
  • 新治療

第7章 全球的睡眠呼吸中止症相關裝置市場、終端使用者層別

  • 簡介

第8章 地區別分析

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區

第9章 競爭環境

  • 簡介
  • 新產品開發
  • 業務合作、合夥、協議、合資事業
  • M&A
  • 其他

第10章 企業檔案資料

目錄

Abstract

Report Description

Sleep problems are touted as a 'global epidemic' and sleep apnea is a crucial contributor to this disorder. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea; around 84% of people with sleep apnea are diagnosed with the disease. Studies suggest that about 100 million people worldwide are suspected to have obstructive sleep apnea, of which more than 80% remain undiagnosed.

The global sleep apnea devices market is broadly segmented into two categories, namely, Diagnostic Devices and Therapeutic Devices. The industry is technology driven and technological advancements in both diagnostic and therapeutic devices such as PSG devices, screening devices, actigraphy systems, Positive Airway Pressure (PAP) devices, humidifiers, adaptive servo-ventilation systems, oxygen devices, oral appliances, and accessories have enhanced patient compliance levels in recent years.

Incessantly rising obesity and incidence of sleep apnea, increasing awareness regarding hypertension, stroke, Type II diabetes/adult onset diabetes and cardiovascular diseases and its association with sleep apnea, increased adoption and acceptance of home sleep testing devices, growing preference for oral appliances, technological advancement in diagnostic/therapeutic devices, and upcoming novel therapies are the major drivers that are slated to propel this market, while limited reimbursement, coupled with lack of patient compliance is a pivotal factor restraining the growth of this market. The market is dominated by global players like Philips Respironics, ResMed, Inc., Natus Medical Incorporated, Fisher and Paykel Healthcare, Compumedics Limited, and CareFusion Corporation, among others.

The diagnostic devices and therapeutic devices segments will grow at a CAGR of 15% and 17%, respectively, by 2017. The diagnostic devices market is propelled by PSG devices, particularly clinical PSG devices. The usage of Ambulatory PSG devices is slated to increase in the next few years due to observed patient preference to be tested at home for convenience reasons, patient's inclination to skip the unfamiliar environment of sleep labs, and cost effectiveness of these devices. The global demand for other diagnostic devices such as respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems is also on the rise due to their low costs. These devices serve as cost-effective and convenient options, as compared to PSG devices, especially for the low-economic class patient pool.

The therapeutic devices market is predominantly driven by PAP devices, as these are considered to be the first line treatment for sleep apnea and hence are most prescribed by sleep specialists. Insurance cover for PAP devices and other supplies in developed geographies like the U.S. and select countries in Europe is expected to boost its demand. However, non- compliance issue with PAP devices is expected to boost the growth of the oral appliances market. The accessories market was the largest in 2011, in terms of volume, as they are an integral component of sleep apnea diagnostic and therapeutic devices. With a growing sleep apnea patient pool, the demand for sleep apnea diagnostic/therapeutic devices and accessories is bound to grow.

The global sleep apnea devices market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the sleep apnea device market in the years to come, followed by Europe. As reimbursement policies become more consistent across European countries, sustained steady growth is expected from the region in the coming years. The Asian region's contribution to the global sleep apnea device market is expected to pick up in the coming years as the medical condition gets more recognition from both patients and the medical fraternity alike.

Scope of the Report

The sleep apnea devices market research report categorizes the global market into Diagnostic Devices and Therapeutic Devices. Both of these markets are broken down into segments and sub-segments, providing exhaustive value-volume analysis for 2009, 2010 and 2011, as well as forecast up to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario. A separate segment of end-user analysis is also incorporated in the report to provide information on devices that are used exclusively at hospital or at home and devices that are used at both places.

Global sleep apnea market, by segments

  • Diagnostic Devices
  • Therapeutic Devices

Global sleep apnea diagnostic devices market, by products

  • Polysomnography (PSG) Devices
    • Clinical PSG Devices
    • Ambulatory PSG Devices
  • Respiratory polygraphs
  • Two Channel Screening Devices (Nasal Flow Sensors, SPO2)
  • Single Channel Screening Devices (Pulse Oximeters)
  • Actigraphy Systems

Global sleep apnea therapeutic devices market, by products

  • Positive Airway Pressure (PAP) Devices
    • CPAP Devices
    • APAP Devices
    • Bi-level Devices
  • Facial Interfaces
    • Masks
      • Full Face Masks
      • Nasal Masks
      • Nasal Pillow Masks
      • Oral Masks
  • Adaptive Servo-Ventilation
  • Airway Clearance Systems
  • Oxygen Devices
    • Concentrators
    • Home Oxygen Filling Systems
    • Liquid Portable Oxygen
  • Accessories
    • Pillows
    • Masks Cleaning Wipes
    • Chin Restraints
    • Tube Covers
    • Filters
    • DC Convertors
    • Power & Batteries
    • Headgears
    • Nebulizers
    • Tubings
    • Humidifiers
    • Others
  • Oral Appliances
    • Mandibular Advancement Device (MAD)
    • Tongue Retaining Device (TRD)
    • Others
  • Novel therapies

Global sleep apnea market, by end-users

  • Home Devices
  • Hospital Devices
  • Both (Home and Hospital) Devices

Sleep apnea market, by geography

  • North America
  • Europe
  • Asia
  • Rest of the World (RoW)

Summary

Sleep apnea is a relatively new market in the medical field, gaining momentum at a fast pace, especially in developed geographies. The demand for sleep apnea devices is slated to increase at a faster pace, owing to gradually increasing awareness among both patients and the medical fraternity.

The penetration level of sleep apnea diagnosis, as well as therapy, is low across the globe, due to the lack of adequate awareness among both patients and physicians. Sleep apnea device manufacturers and hospitals, however, are actively engaged in educating primary care givers, sleep specialists, and patients about the disorder, informing them of available diagnostic and therapeutic options. Riding on these efforts, sleep apnea is now being recognized as a serious medical condition, which, if left untreated, can have fatal results.

The global sleep apnea devices market was valued at $7.96 billion in the year 2011 and is expected to reach $19.72 billion in the year 2017. North America was the largest sleep apnea devices market, followed by Europe, and Asia. In the next few years, North America will continue to lead the sleep apnea device market, followed by Europe. The Asian region's contribution to the global sleep apnea device market is expected to pick up in the coming years as the medical condition gets more recognition.

The global sleep apnea devices market is broadly classified into two segments, namely, Diagnostic Devices, and Therapeutic devices. Incessantly rising obesity and incidence of sleep apnea, increasing awareness regarding hypertension, stroke, Type II diabetes/adult onset diabetes, and cardiovascular diseases and their association with sleep apnea, increased adoption and acceptance of home sleep testing devices, growing preference for oral appliances, technological advancement in diagnostic/therapeutic devices, and upcoming novel therapies are expected to drive the global sleep apnea devices market in the next few years.

The global sleep apnea devices market is witnessing high competitive intensity. Segment rivalry is high, as there are a few well-established firms and several small firms with similar product offerings. The market is dominated by Philips Respironics and ResMed, Inc., which jointly comprise 70% of the market. Fisher and Paykel Healthcare, CareFusion Corporation, Natus Medical Incorporated, DeVilbiss Healthcare, Weinmann Medical Devices, etc. are a few of the other prominent players in the global sleep apnea devices market.

image1

Table of Contents

1 INTRODUCTION

  • 1.1 KEY TAKE-AWAYS
  • 1.2 REPORT DESCRIPTION
  • 1.3 MARKETS COVERED
  • 1.4 STAKEHOLDERS
  • 1.5 RESEARCH METHODOLOGY
    • 1.5.1 MARKET SIZE
    • 1.5.2 MARKET SHARE
    • 1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
    • 1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
    • 1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW

  • 3.1 INTRODUCTION
    • 3.1.1 STAGES OF SLEEP
      • 3.1.1.1 Sleep Cycle
    • 3.1.2 SLEEP DISORDERS
    • 3.1.3 SLEEP APNEA
    • 3.1.4 ANATOMY OF SLEEP APNEA EPISODE
    • 3.1.5 CLASSIFICATION OF SLEEP APNEA
    • 3.1.6 CAUSES
      • 3.1.6.1 Central sleep apnea (CSA)
      • 3.1.6.2 Obstructive sleep apnea (OSA)
    • 3.1.7 SIGNS & SYMPTOMS
      • 3.1.7.1 Central sleep apnea
      • 3.1.7.2 Obstructive sleep apnea
      • 3.1.7.3 Signs and symptoms in children
    • 3.1.8 RISK FACTORS
      • 3.1.8.1 Central sleep apnea
      • 3.1.8.2 Obstructive Sleep Apnea
    • 3.1.9 DIAGNOSIS
      • 3.1.9.1 Sleep apnea diagnosis & sleep recording test
    • 3.1.10 TREATMENT OPTIONS
    • 3.1.11 CO-MORBID CONDITIONS
  • 3.2 MARKET DYNAMICS
    • 3.2.1 PORTER'S FIVE FORCES ANALYSIS
      • 3.2.1.1 Threat of new entrants
      • 3.2.1.2 Supplier's bargaining power
      • 3.2.1.3 Buyer's bargaining power
      • 3.2.1.4 Segment rivalry
      • 3.2.1.5 Threat of substitutes
    • 3.2.2 DRIVERS
      • 3.2.2.1 Colossal pool of sleep apnea patients
      • 3.2.2.2 Increasing awareness
      • 3.2.2.3 Growing usage of oral appliances
      • 3.2.2.4 Technological advancements
    • 3.2.3 RESTRAINTS
      • 3.2.3.1 Reimbursement concerns
      • 3.2.3.2 Lack of patient compliance
    • 3.2.4 MARKET SHARE, BY KEY PLAYERS

4 GLOBAL SLEEP APNEA DEVICES MARKET, BY SEGMENTS

  • 4.1 INTRODUCTION

5 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCTS

  • 5.1 INTRODUCTION
  • 5.2 POLYSOMNOGRAPHY (PSG) DEVICE
    • 5.2.1 CLINICAL PSG DEVICE
    • 5.2.2 AMBULATORY PSG DEVICE
  • 5.3 RESPIRATORY POLYGRAPH
  • 5.4 TWO CHANNEL SCREENING DEVICES (NASAL FLOW SENSORS, SPO2)
  • 5.5 SINGLE CHANNEL SCREENING DEVICES (PULSE OXIMETERS)
    • 5.5.1 HAND-HELD PULSE OXIMETERS
    • 5.5.2 FINGERTIP PULSE OXIMETERS
    • 5.5.3 TABLE-TOP PULSE OXIMETERS
    • 5.5.4 WRIST-WORN PULSE OXIMETERS
  • 5.6 ACTIGRAPHY SYSTEMS

6 GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCTS

  • 6.1 INTRODUCTION
  • 6.2 POSITIVE AIRWAY PRESSURE (PAP) DEVICE
    • 6.2.1 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICE
    • 6.2.2 AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICE
    • 6.2.3 BILEVEL (BPAP) DEVICE
  • 6.3 FACIAL INTERFACES
    • 6.3.1 MASKS
      • 6.3.1.1 Full face masks
      • 6.3.1.2 Nasal masks
      • 6.3.1.3 Nasal pillow masks
      • 6.3.1.4 Oral masks
  • 6.4 ADAPTIVE SERVO-VENTILATION (ASV)
  • 6.5 AIRWAY CLEARANCE SYSTEMS
  • 6.6 OXYGEN DEVICES
    • 6.6.1 CONCENTRATORS
    • 6.6.2 HOME OXYGEN FILLING SYSTEMS
    • 6.6.3 LIQUID PORTABLE OXYGEN
  • 6.7 ACCESSORIES
    • 6.7.1 PILLOWS
    • 6.7.2 MASKS CLEANING WIPES
    • 6.7.3 CHIN RESTRAINTS
    • 6.7.4 TUBE COVERS
    • 6.7.5 FILTERS
    • 6.7.6 DC CONVERTORS
    • 6.7.7 POWER & BATTERIES
    • 6.7.8 HEADGEAR
    • 6.7.9 NEBULIZERS
    • 6.7.10 TUBINGS
    • 6.7.11 HUMIDIFIERS
    • 6.7.12 OTHERS
  • 6.8 ORAL APPLIANCES
    • 6.8.1 MANDIBULAR ADVANCEMENT DEVICE (MAD)
    • 6.8.2 TONGUE RETAINING DEVICE (TRD)
    • 6.8.3 OTHERS
      • 6.8.3.1 Boil and bite appliances
      • 6.8.3.2 Laboratory - fabricated appliances
        • 6.8.3.2.1 Klearway appliance
        • 6.8.3.2.2 Thornton adjustable positioners (TAP)
        • 6.8.3.2.3 Herbst appliance
      • 6.8.3.3 Nocturnal airway patency appliance (NAPA)
      • 6.8.3.4 Oral pressure appliance (OPAP)
  • 6.9 NOVEL THERAPIES
    • 6.9.1 NEUROSTIMULATION
      • 6.9.1.1 Upper airway stimulation therapy by Inspire Medical Systems
      • 6.9.1.2 Hypoglossal nerve stimulation system by Apnex Medical, Inc.
      • 6.9.1.3 Targeted hypoglossal neurostimulation (THN) sleep therapy by Imthera Medical
    • 6.9.2 SLEEP POSITION TRAINER, BY NIGHTBALANCE
    • 6.9.3 PROVENT THERAPY, BY VENTUS MEDICAL
    • 6.9.4 WINX SLEEP THERAPY SYSTEM, BY APNICURE

7 GLOBAL SLEEP APNEA DEVICES MARKET, BY END-USERS

  • 7.1 INTRODUCTION

8 GEOGRAPHIC ANALYSIS

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
  • 8.3 EUROPE
  • 8.4 ASIA
  • 8.5 REST OF THE WORLD (ROW)

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 NEW PRODUCTS DEVELOPMENTS
  • 9.3 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/JOINT VENTURES
  • 9.4 MERGERS & ACQUISITIONS
  • 9.5 OTHERS

10 COMPANY PROFILES

  • 10.1 APNEX MEDICAL, INC.
    • 10.1.1 OVERVIEW
    • 10.1.2 FINANCIALS
    • 10.1.3 PRODUCTS & SERVICES
    • 10.1.4 STRATEGY
    • 10.1.5 DEVELOPMENTS
  • 10.2 BMC MEDICAL CO., LTD.
    • 10.2.1 OVERVIEW
    • 10.2.2 FINANCIALS
    • 10.2.3 PRODUCTS & SERVICES
    • 10.2.4 STRATEGY
    • 10.2.5 DEVELOPMENTS
  • 10.3 BRAEBON MEDICAL CORPORATION
    • 10.3.1 OVERVIEW
    • 10.3.2 FINANCIALS
    • 10.3.3 PRODUCTS & SERVICES
    • 10.3.4 STRATEGY
    • 10.3.5 DEVELOPMENTS
  • 10.4 CADWELL LABORATORIES, INC.
    • 10.4.1 OVERVIEW
    • 10.4.2 FINANCIALS
    • 10.4.3 PRODUCTS & SERVICES
    • 10.4.4 STRATEGY
    • 10.4.5 DEVELOPMENTS
  • 10.5 CAREFUSION CORPORATION
    • 10.5.1 OVERVIEW
    • 10.5.2 FINANCIALS
    • 10.5.3 PRODUCTS & SERVICES
    • 10.5.4 STRATEGY
    • 10.5.5 DEVELOPMENTS
  • 10.6 COMPUMEDICS LIMITED
    • 10.6.1 OVERVIEW
    • 10.6.2 FINANCIALS
    • 10.6.3 PRODUCTS
    • 10.6.4 STRATEGY
    • 10.6.5 DEVELOPMENTS
  • 10.7 CURATIVE MEDICAL, INC.
    • 10.7.1 OVERVIEW
    • 10.7.2 FINANCIALS
    • 10.7.3 PRODUCTS & SERVICES
    • 10.7.4 STRATEGY
    • 10.7.5 DEVELOPMENTS
  • 10.8 FISHER AND PAYKEL HEALTHCARE, LTD.
    • 10.8.1 OVERVIEW
    • 10.8.2 FINANCIALS
    • 10.8.3 PRODUCTS & SERVICES
    • 10.8.4 STRATEGY
    • 10.8.5 DEVELOPMENTS
  • 10.9 GE HEALTHCARE
    • 10.9.1 OVERVIEW
    • 10.9.2 FINANCIALS
    • 10.9.3 PRODUCTS & SERVICES
    • 10.9.4 STRATEGY
    • 10.9.5 DEVELOPMENTS
  • 10.10 GLOBAL MEDICAL HOLDINGS, LLC
    • 10.10.1 OVERVIEW
    • 10.10.2 FINANCIALS
    • 10.10.3 PRODUCTS
    • 10.10.4 STRATEGY
    • 10.10.5 DEVELOPMENTS
  • 10.11 IMTHERA MEDICAL, INC.
    • 10.11.1 OVERVIEW
    • 10.11.2 FINANCIALS
    • 10.11.3 PRODUCTS
    • 10.11.4 STRATEGY
    • 10.11.5 DEVELOPMENTS
  • 10.12 INVACARE CORPORATION
    • 10.12.1 OVERVIEW
    • 10.12.2 FINANCIALS
    • 10.12.3 PRODUCT & SERVICES
    • 10.12.4 STRATEGY
    • 10.12.5 DEVELOPMENTS
  • 10.13 ITAMAR MEDICAL, LTD.
    • 10.13.1 OVERVIEW
    • 10.13.2 FINANCIALS
    • 10.13.3 PRODUCTS & SERVICES
    • 10.13.4 STRATEGY
    • 10.13.5 DEVELOPMENTS
  • 10.14 NATUS MEDICAL, INC.
    • 10.14.1 OVERVIEW
    • 10.14.2 FINANCIALS
    • 10.14.3 PRODUCTS & SERVICES
    • 10.14.4 STRATEGY
    • 10.14.5 DEVELOPMENTS
  • 10.15 NIHON KOHDEN
    • 10.15.1 OVERVIEW
    • 10.15.2 FINANCIALS
    • 10.15.3 PRODUCTS & SERVICES
    • 10.15.4 STRATEGY
    • 10.15.5 DEVELOPMENTS
  • 10.16 PHILIPS HEALTHCARE
    • 10.16.1 OVERVIEW
    • 10.16.2 FINANCIALS
    • 10.16.3 PRODUCTS & SERVICES
    • 10.16.4 STRATEGY
    • 10.16.5 DEVELOPMENTS
  • 10.17 RESMED, INC.
    • 10.17.1 OVERVIEW
    • 10.17.2 FINANCIALS
    • 10.17.3 PRODUCTS & SERVICES
    • 10.17.4 STRATEGY
    • 10.17.5 DEVELOPMENTS
  • 10.18 SOMNETICS INTERNATIONAL, INC.
    • 10.18.1 OVERVIEW
    • 10.18.2 FINANCIALS
    • 10.18.3 PRODUCTS
    • 10.18.4 STRATEGY
    • 10.18.5 DEVELOPMENTS
  • 10.19 SOMNOMEDICS GMBH
    • 10.19.1 OVERVIEW
    • 10.19.2 FINANCIALS
    • 10.19.3 PRODUCTS & SERVICES
    • 10.19.4 STRATEGY
    • 10.19.5 DEVELOPMENTS
  • 10.20 TELEFLEX, INC.
    • 10.20.1 OVERVIEW
    • 10.20.2 FINANCIALS
    • 10.20.3 PRODUCTS & SERVICES
    • 10.20.4 STRATEGY
    • 10.20.5 DEVELOPMENTS
  • 10.21 VENTUS MEDICAL, INC.
    • 10.21.1 OVERVIEW
    • 10.21.2 FINANCIALS
    • 10.21.3 PRODUCTS
    • 10.21.4 STRATEGY
    • 10.21.5 DEVELOPMENTS
  • 10.22 WEINMANN MEDICAL DEVICES GMBH & CO. KG
    • 10.22.1 OVERVIEW
    • 10.22.2 FINANCIALS
    • 10.22.3 PRODUCTS & SERVICES
    • 10.22.4 STRATEGY
    • 10.22.5 DEVELOPMENTS

LIST OF TABLES

  • TABLE 1 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, BY SEGMENTS, 2009 - 2017 ($BILLION)
  • TABLE 2 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 3 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 4 GLOBAL PSG DEVICE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)
  • TABLE 5 GLOBAL PSG DEVICE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 6 CLINICAL PSG DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 7 CLINICAL PSG DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 8 AMBULATORY PSG DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 9 AMBULATORY PSG DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 10 RESPIRATORY POLYGRAPH MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 11 RESPIRATORY POLYGRAPH MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 12 TWO CHANNEL SCREENING DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 13 TWO CHANNEL SCREENING DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 14 GLOBAL SINGLE CHANNEL SCREENING DEVICE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)
  • TABLE 15 GLOBAL SINGLE CHANNEL SCREENING DEVICE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 16 HAND-HELD PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 17 HAND-HELD PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 18 FINGERTIP PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 19 FINGERTIP PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 20 TABLE-TOP PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 21 TABLE-TOP PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 22 WRIST-WORN PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 23 WRIST-WORN PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 24 ACTIGRAPHY SYSTEM MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 25 ACTIGRAPHY SYSTEM MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 26 GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 27 GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 28 GLOBAL PAP DEVICE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)
  • TABLE 29 GLOBAL PAP DEVICE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 30 CPAP DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 31 CPAP DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 32 APAP DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 33 APAP DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 34 BILEVEL DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 35 BILEVEL DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 36 GLOBAL MASKS MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)
  • TABLE 37 GLOBAL MASKS MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 38 FULL FACE MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 39 FULL FACE MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 40 NASAL MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 41 NASAL MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 42 NASAL PILLOW MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 43 NASAL PILLOW MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 44 ORAL MASKS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 45 ORAL MASKS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 46 ADAPTIVE SERVO-VENTILATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 47 ADAPTIVE SERVO-VENTILATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 48 AIRWAY CLEARANCE SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 49 AIRWAY CLEARANCE SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 50 GLOBAL OXYGEN DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 51 GLOBAL OXYGEN DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 52 CONCENTRATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 53 CONCENTRATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 54 HOME OXYGEN FILLING SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 55 HOME OXYGEN FILLING SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 56 LIQUID PORTABLE OXYGEN MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 57 LIQUID PORTABLE OXYGEN MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 58 GLOBAL ACCESSORIES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 59 GLOBAL ACCESSORIES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 60 PILLOWS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 61 PILLOWS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 62 MASKS CLEANING WIPES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 63 MASKS CLEANING WIPES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 64 CHIN RESTRAINTS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 65 CHIN RESTRAINTS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 66 TUBE COVERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 67 TUBE COVERS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 68 FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 69 FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 70 DC CONVERTORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 71 DC CONVERTORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 72 POWER & BATTERIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 73 POWER & BATTERIES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 74 HEADGEAR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 75 HEADGEAR MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 76 NEBULIZER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 77 NEBULIZER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 78 TUBING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 79 TUBING MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 80 HUMIDIFIER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 81 HUMIDIFIER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 82 OTHER ACCESSORIES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 83 GLOBAL ORAL APPLIANCE MARKET REVENUE, BY TYPES, 2009 - 2017 ($MILLION)
  • TABLE 84 GLOBAL ORAL APPLIANCE MARKET VOLUME, BY TYPES, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 85 MANDIBULAR ADVANCEMENT DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 86 MANDIBULAR ADVANCEMENT DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 87 TONGUE RETAINING DEVICE MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 88 TONGUE RETAINING DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 89 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)
  • TABLE 90 SLEEP APNEA DEVICES END-USERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($MILLION)
  • TABLE 91 NORTH AMERICA: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)
  • TABLE 92 EUROPE: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)
  • TABLE 93 ASIA: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)
  • TABLE 94 ROW: SLEEP APNEA DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2017 ($MILLION)
  • TABLE 95 SLEEP APNEA DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($BILLION)
  • TABLE 96 SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2017 ($BILLION)
  • TABLE 97 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 98 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 99 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 100 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 101 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 102 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 103 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 104 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 105 ASIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 106 ASIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 107 ASIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 108 ASIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 109 ROW: SLEEP APNEA DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 110 ROW: SLEEP APNEA DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 111 ROW: SLEEP APNEA THERAPEUTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2017 ($MILLION)
  • TABLE 112 ROW: SLEEP APNEA THERAPEUTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2017 (THOUSAND UNITS)
  • TABLE 113 NEW PRODUCTS DEVELOPMENTS, 2009 - 2012
  • TABLE 114 COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/ JOINT VENTURES, 2010 - 2012
  • TABLE 115 MERGERS & ACQUISITIONS, 2009 - 2011
  • TABLE 116 OTHERS, 2009 - 2012
  • TABLE 117 CAREFUSION CORP.: NET REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 118 CAREFUSION CORP.: NET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 119 CAREFUSION CORP.: NET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 120 COMPUMEDICS LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 121 COMPUMEDICS LTD.: SLEEP MONITORING SEGMENT REVENUE, 2009 - 2011 ($MILLION)
  • TABLE 122 COMPUMEDICS LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 123 FISHER AND PAYKEL HEALTHCARE, LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 124 FISHER AND PAYKEL HEALTHCARE, LTD.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 125 FISHER AND PAYKEL HEALTHCARE, LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 126 GENERAL ELECTRIC CO.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 127 GENERAL ELECTRIC CO.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 128 GENERAL ELECTRIC CO.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 129 INVACARE CORP.: NET SALES AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 130 INVACARE CORP.: NET SALES BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 131 INVACARE CORP.: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 132 NATUS MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 133 NATUS MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 134 NIHON KOHDEN: NET SALES AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 135 NIHON KOHDEN: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 136 NIHON KOHDEN: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 137 ROYAL PHILIPS ELECTRONICS: NET SALES AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 138 ROYAL PHILIPS ELECTRONICS: NET SALES, 2009 - 2011 ($MILLION)
  • TABLE 139 PHILIPS HEALTHCARE: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 140 ROYAL PHILIPS ELECTRONICS: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 141 RESMED, INC.: NET REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 142 RESMED, INC.: NET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 143 RESMED, INC.: NET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 144 SOMNOMEDICS GMBH: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2010 ($MILLION)
  • TABLE 145 TELEFLEX, INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 146 TELEFLEX, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 147 TELEFLEX, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)

LIST OF FIGURES

  • FIGURE 1 SLEEP APNEA DEVICES MARKET, GEOGRAPHICAL RANKING, 2011
  • FIGURE 2 GLOBAL SLEEP APNEA DEVICES MARKET REVENUE, 2011 & 2017 ($BILLION)
  • FIGURE 3 TYPES OF SLEEP APNEA
  • FIGURE 4 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 5 THREAT OF NEW ENTRANTS
  • FIGURE 6 SUPPLIER'S BARGAINING POWER
  • FIGURE 7 BUYER'S BARGAINING POWER
  • FIGURE 8 SEGMENT RIVALRY
  • FIGURE 9 THREAT OF SUBSTITUTES
  • FIGURE 10 GLOBAL SLEEP APNEA DEVICES MARKET SHARE, BY KEY PLAYERS, 2011
  • FIGURE 11 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SHARE, BY KEY PLAYERS, 2011
  • FIGURE 12 GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE, BY KEY PLAYERS, 2011
  • FIGURE 13 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES, BY PRODUCTS
  • FIGURE 14 GLOBAL SLEEP APNEA THERAPEUTIC DEVICES, BY PRODUCTS
  • FIGURE 15 GLOBAL SLEEP APNEA DEVICES MARKET SHARE, BY END-USERS, 2011 & 2017
  • FIGURE 16 KEY GROWTH STRATEGIES, MARCH 2009 - JUNE 2012
新聞稿

睡眠呼吸中止症治療儀器的全球市場2017年將達到197億美元的規模

2012年08月14日

Global Information, Inc.開始銷售Markets and Markets所發行的報告書「Sleep Apnea Diagnostic & Therapeutic Devices Market: Global End-user Analysis, Competitive Landscape & Forecast to 2017 (睡眠呼吸中止症的診斷・治療裝置市場：全球的終端使用者分析、競爭環境、將來預測)」

本報告提供北美，歐洲，亞洲，以及全球各地區的睡眠呼吸中止症的治療用設備市場相關資料，調查分析結果彙整，主要市場推動成長要素及阻礙因素，市場機會的到2017年為止的預測。

睡眠障礙在全球蔓延"，在這之中特別是患者數最多的是睡眠呼吸中止症。其中約84％被診斷為阻塞型睡眠呼吸中止症(OSA)。根據研究指出，全球有1億人以上疑似OSA，其中 80％以上診斷未確定。

睡眠呼吸中止症在醫療領域中為較新的市場。也是先進各國開始急速增加的市場。由於醫生和患者雙方之間，針對治療設備的關注急速提高，需求將急速成長。

2011年達到79億6,000萬美元左右的全球睡眠障礙治療設備市場，預計在2017年將擴大到197億2,000萬美元規模。最大市場為北美，接著則是歐洲，亞洲。今後數年北美將持續成為最大市場，其次還是歐洲市場，同時期亞洲市場由於逐漸提高對病情的認識，市場將進一步擴大。

分為診斷用設備及治療用設備的睡眠呼吸中止症的治療相關設備，面臨全球市場快速的激烈競爭。由於不同規模的各企業提供同樣的產品，相關產品領域的競爭逐漸激烈。Philips Respironics和ResMed, Inc. 主導市場，這2間公司合計的市場佔有率達到70％。其他全球市場的主要經營者有Fisher and Paykel Healthcare和CareFusion Corporation，Natus Medical Incorporated，DeVilbiss Healthcare，Weinmann Medical Devices等。

睡眠呼吸中止症的診斷・治療裝置市場：全球的終端使用者分析、競爭環境、將來預測是由出版商Markets and Markets在2012年07月25日所出版的。這份市場調查報告書包含318 Pages 價格從美金4650起跳。
Back to Top
;